DK0768867T3 - Doseringsform til indgivelse af lægemiddel i væskeformig formulering - Google Patents

Doseringsform til indgivelse af lægemiddel i væskeformig formulering

Info

Publication number
DK0768867T3
DK0768867T3 DK94920203T DK94920203T DK0768867T3 DK 0768867 T3 DK0768867 T3 DK 0768867T3 DK 94920203 T DK94920203 T DK 94920203T DK 94920203 T DK94920203 T DK 94920203T DK 0768867 T3 DK0768867 T3 DK 0768867T3
Authority
DK
Denmark
Prior art keywords
dosage form
drug
administration
liquid formulation
disclosed
Prior art date
Application number
DK94920203T
Other languages
Danish (da)
English (en)
Inventor
Steven D Larsen
George V Guittard
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0768867T3 publication Critical patent/DK0768867T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94920203T 1994-06-13 1994-06-13 Doseringsform til indgivelse af lægemiddel i væskeformig formulering DK0768867T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
DK0768867T3 true DK0768867T3 (da) 2002-10-28

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94920203T DK0768867T3 (da) 1994-06-13 1994-06-13 Doseringsform til indgivelse af lægemiddel i væskeformig formulering

Country Status (11)

Country Link
EP (1) EP0768867B1 (de)
JP (1) JP3901727B2 (de)
KR (1) KR100360636B1 (de)
AT (1) ATE225647T1 (de)
AU (1) AU682703B2 (de)
CA (1) CA2185119C (de)
DE (1) DE69431533T2 (de)
DK (1) DK0768867T3 (de)
ES (1) ES2183841T3 (de)
PT (1) PT768867E (de)
WO (1) WO1995034285A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6673768B1 (en) 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
KR100620292B1 (ko) * 1998-09-09 2006-09-13 알자 코포레이션 액체 제형물을 포함하는 제형
EP1140012B1 (de) * 1998-12-17 2004-03-03 Alza Corporation Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2363112B8 (de) 2006-08-09 2018-11-21 Intarcia Therapeutics, Inc. Osmotisches Verabreichungssystem mit KOLBENANORDNUNG
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CA2743789C (en) 2008-11-16 2017-10-31 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
AU2010298733B2 (en) 2009-09-28 2014-10-09 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (de) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Systeme zum einsetzen eines implantats
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
DK3735228T3 (da) 2018-03-05 2022-03-14 Amneal Complex Products Res Llc Programmerbar farmaceutiske sammensætninger til krono-lægemiddelfrigivelse
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
US11547670B2 (en) 2019-03-05 2023-01-10 Amneal Complex Products Research Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
CA2185119C (en) 2005-07-26
WO1995034285A1 (en) 1995-12-21
EP0768867B1 (de) 2002-10-09
JP3901727B2 (ja) 2007-04-04
KR100360636B1 (ko) 2002-12-18
DE69431533T2 (de) 2003-10-02
KR970703752A (ko) 1997-08-09
PT768867E (pt) 2003-01-31
EP0768867A1 (de) 1997-04-23
JPH10501261A (ja) 1998-02-03
AU7108094A (en) 1996-01-05
ES2183841T3 (es) 2003-04-01
ATE225647T1 (de) 2002-10-15
CA2185119A1 (en) 1995-12-21
AU682703B2 (en) 1997-10-16
DE69431533D1 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE116543T1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
JO1502B1 (en) New pharmacy vehicles
DK135389D0 (da) Osmotisk indretning til administration af en terapeutisk effektiv maengde laegemiddel
ID25988A (id) FORMULASI OBAT YANG LARUTNYA BISA DIATUR (Pecahan dari P-940726)
ATE427103T1 (de) Orale verabreichung von adenosin analogen
DE69434626D1 (de) Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
DK1006935T3 (da) Styret afgivelsessystem med en væske med höj viskositet
SE8804629D0 (sv) New therapeutically active compounds
DE60019334D1 (de) Antivirale arznei
ES2125679T3 (es) Sistema transdermico de administracion simultanea de varios principios activos.
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
MY101784A (en) Novel pharmacological compounds
DK1112060T3 (da) Doseringsform anvendende flydende formulering
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
SE8404065D0 (sv) Novel biologically active compounds
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
ES2125354T3 (es) Composicion a base de tandospirona o de sus analogos.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE525078T1 (de) Kyberdrug als autovakzine mit immunregulierenden wirkungen
DK464483A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
HK1029277A1 (en) Pharmaceutical coating composition and method of use.